A Comprehensive RNA Expression Signature for Cervical Squamous Cell Carcinoma Prognosis

A Comprehensive RNA Expression Signature for Cervical Squamous Cell Carcinoma Prognosis

Clinicopathological characteristics alone are not enough to predict the survival of patients with cervical squamous cell carcinoma (CESC) due to clinical heterogeneity. In recent years, many genes and non-coding RNAs have been shown to be oncogenes or tumor-suppressors in CESC cells. This study aime...

Full description

Bibliographic Details
Main Authors:	Jie Xiong, Shengyu Guo, Zhitong Bing, Yanlin Su, Le Guo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-01-01
Series:	Frontiers in Genetics
Subjects:	transcriptome signature prognosis CESC angiogenesis
Online Access:	https://www.frontiersin.org/article/10.3389/fgene.2018.00696/full

Similar Items

Prediction of Prognosis and Chemotherapeutic Sensitivity Based on Cuproptosis-Associated lncRNAs in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma
by: Jianghong Zhou, et al.
Published: (2023-06-01)

RNA-binding proteins signature is a favorable biomarker of prognosis, immunotherapy and chemotherapy response for cervical cancer
by: Xiaomei Chen, et al.
Published: (2024-02-01)

Lumican is a potential predictor on the efficacy of concurrent chemoradiotherapy in cervical squamous cell carcinoma
by: Ge Hu, et al.
Published: (2023-07-01)

High Expression of TMEM33 Predicts Poor Prognosis and Promotes Cell Proliferation in Cervical Cancer
by: Hanxiang Chen, et al.
Published: (2022-06-01)

Prognostic Significance of Alternative Splicing Genes in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma
by: Wang X, et al.
Published: (2021-11-01)

Identification and validation of a novel necroptosis-related prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma
by: Weiyu Zhang, et al.
Published: (2022-09-01)

Development and validation of an autophagy-related long non-coding RNA prognostic signature for cervical squamous cell carcinoma and endocervical adenocarcinoma
by: Shuguang Zhou, et al.
Published: (2022-11-01)

Serum lncRNAs (CCAT2, LINC01133, LINC00511) with Squamous Cell Carcinoma Antigen Panel as Novel Non-Invasive Biomarkers for Detection of Cervical Squamous Carcinoma
by: Wang WJ, et al.
Published: (2020-10-01)

Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma
by: Chen Han, et al.
Published: (2021-12-01)

Angiogenesis-Related Gene Expression Signatures Predicting Prognosis in Gastric Cancer Patients
by: Haoyu Ren, et al.
Published: (2020-12-01)

The Prognostic and Immune Significance of BZW2 in Pan-Cancer and its Relationship with Proliferation and Apoptosis of Cervical Cancer
by: Chaolin Li, et al.
Published: (2024-03-01)

SET and MYND domain-containing protein 2 (SMYD2): A prognostic biomarker associated with immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma
by: An Zhanglu, et al.
Published: (2022-01-01)

A novel angiogenesis-based molecular signature related to prognosis and tumor immune interactions of pancreatic cancer
by: Weiyu Ge, et al.
Published: (2022-10-01)

Identification and validation of a novel tumor driver gene signature for diagnosis and prognosis of head and neck squamous cell carcinoma
by: Shixian Liu, et al.
Published: (2022-10-01)

Exploring Immune-Related Gene Profiling and Infiltration of Immune Cells in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma
by: Jialu Li, et al.
Published: (2024-01-01)

A novel lipid metabolism-related lncRNA signature predictive of clinical prognosis in cervical cancer
by: Yanzhen Lu, et al.
Published: (2022-10-01)

Exploring Potential Regulatory Anesthetic Drugs Based on RNA Binding Protein and Constructing CESC Prognosis Model: A Study Based on TCGA Database
by: Ying Zheng, et al.
Published: (2022-04-01)

The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma
by: Cheng-Yuan Gu, et al.
Published: (2022-07-01)

Novel Model for Comprehensive Assessment of Robust Prognostic Gene Signature in Ovarian Cancer Across Different Independent Datasets
by: Zhitong Bing, et al.
Published: (2019-10-01)

Identification of a DNA damage repair gene‐related signature for lung squamous cell carcinoma prognosis
by: Bin Jia, et al.
Published: (2022-04-01)

A Hypoxia-Related miRNA-mRNA Signature for Predicting the Response and Prognosis of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma
by: Zong S, et al.
Published: (2024-03-01)

Uncovering of potential molecular markers for cervical squamous cell carcinoma (CESC) based on analysis of methylated-differentially expressed genes
by: Miaomiao Liu, et al.
Published: (2022-07-01)

Comprehensive Characterization of Immune Landscape Based on Tumor Microenvironment for Oral Squamous Cell Carcinoma Prognosis
by: Qi-Lin Li, et al.
Published: (2022-09-01)

Construction of a Necroptosis-Related miRNA Signature for Predicting the Prognosis of Patients With Hepatocellular Carcinoma
by: Tongyu Meng, et al.
Published: (2022-04-01)

Construction and validation of an angiogenesis-related gene expression signature associated with clinical outcome and tumor immune microenvironment in glioma
by: Tianhao Hu, et al.
Published: (2022-08-01)

Development and Validation of an Immune-Related lncRNA Signature for Predicting the Prognosis of Hepatocellular Carcinoma
by: Weihao Kong, et al.
Published: (2020-09-01)

Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma
by: Fangxing Xu, et al.
Published: (2022-12-01)

Development of an Immune-Related Risk Signature for Predicting Prognosis in Lung Squamous Cell Carcinoma
by: Denggang Fu, et al.
Published: (2020-08-01)

A novel cuproptosis-related gene signature for predicting prognosis in cervical cancer
by: Lei Lei, et al.
Published: (2022-08-01)

An Extracellular Matrix-Based Signature Associated With Immune Microenvironment Predicts the Prognosis and Therapeutic Responses of Patients With Oesophageal Squamous Cell Carcinoma
by: Hongpan Zhang, et al.
Published: (2021-03-01)

Establishment and Validation of a Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Lower-Grade Glioma
by: Qian-Rong Huang, et al.
Published: (2022-06-01)

A Metabolic Plasticity-Based Signature for Molecular Classification and Prognosis of Lower-Grade Glioma
by: Ming-Chun Yang, et al.
Published: (2022-08-01)

A novel gene signature related to focal adhesions for distinguishing and predicting the prognosis of lung squamous cell carcinoma
by: Gang Hui, et al.
Published: (2024-01-01)

High expression of stromal signatures correlated with macrophage infiltration, angiogenesis and poor prognosis in glioma microenvironment
by: Yixin Tian, et al.
Published: (2020-05-01)

A 16-gene signature predicting prognosis of patients with oral tongue squamous cell carcinoma
by: Zeting Qiu, et al.
Published: (2017-11-01)

Immune-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma
by: Yangyang She, et al.
Published: (2020-01-01)

Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis
by: Xin Yang, et al.
Published: (2021-05-01)

Crosstalk of angiogenesis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in colorectal adenocarcinoma
by: Guoliang Cui, et al.
Published: (2022-11-01)

Construction of a ferroptosis and hypoxia-related gene signature in cervical cancer to assess tumour immune microenvironment and predict prognosis
by: Haiyan Wu, et al.
Published: (2024-12-01)

Angiogenesis-Related Molecular Subtypes and a Novel Prognostic Signature in Clear Cell Renal Cell Carcinoma Patients
by: Li H, et al.
Published: (2021-10-01)